Related Experiment Videos
Vanadate stimulates bone cell proliferation and bone collagen synthesis in vitro
K H Lau1, H Tanimoto, D J Baylink
1Department of Medicine, Loma Linda University, California.
Endocrinology
|December 1, 1988
Summary
Orthovanadate, a phosphatase inhibitor, stimulates bone formation by increasing osteoblast proliferation and differentiation. It potentiates growth factors involved in tyrosyl protein phosphorylation, supporting the hypothesis that inhibiting phosphatases enhances bone cell activity.
Area of Science:
- Biochemistry
- Cell Biology
- Orthopedics
Background:
- Fluoride stimulates osteoblast proliferation by inhibiting phosphotyrosyl protein phosphatase activity.
- Understanding the molecular mechanisms of osteogenesis is crucial for developing bone-related therapies.
Purpose of the Study:
- To investigate if orthovanadate, a phosphotyrosyl protein phosphatase inhibitor, mimics fluoride's osteogenic effects.
- To determine orthovanadate's impact on bone cell proliferation and collagen synthesis in vitro.
Main Methods:
- Assessing orthovanadate's effect on osteoblastic acid phosphatase activity.
- Measuring bone cell proliferation and alkaline phosphatase activity in cultured calvarial cells.
- Quantifying bone collagen synthesis using [3H]proline incorporation and conversion in organ cultures.
- Evaluating orthovanadate's interaction with various growth factors in bone cell proliferation assays.
Main Results:
- Orthovanadate inhibited osteoblastic acid phosphatase activity and stimulated bone cell proliferation at low concentrations (5-15 microM).
- Orthovanadate increased alkaline phosphatase and stimulated bone collagen synthesis, indicating enhanced osteoblast differentiation and bone formation.
- Orthovanadate synergistically potentiated mitogenic effects of growth factors involving tyrosyl protein phosphorylation but had an additive effect with basic fibroblast growth factor.
Conclusions:
- Orthovanadate stimulates bone formation by enhancing osteoblast proliferation and differentiation.
- Inhibiting osteoblastic phosphotyrosyl protein phosphatases can prolong/potentiate growth factor actions, thereby stimulating cell proliferation.
- These findings support the hypothesis that targeting phosphotyrosyl protein phosphatases is a viable strategy for promoting bone formation.